Amedea Pharma Announces Winners of Medical Innovation Olympics
Amedea Pharma has recognized DIAPIN Therapeutics and Adelle Diagnostics as gold medalists in its fifth annual Medical Innovation Olympics competition.
Amedea Pharma has announced the winners of its 2026 Medical Innovation Olympics. DIAPIN Therapeutics received the gold award for Product, while Adelle Diagnostics won gold for Concept.
The finalists will present their innovations in San Francisco during the J.P. Morgan 2027 Healthcare Conference. This event aims to foster advancements in healthcare by identifying promising new technologies and approaches.
Jessica Reed, CEO of DIAPIN Therapeutics, and Maria Grazia Ruocco, CEO/Co-Founder of Adelle Diagnostics, accepted their awards at a ceremony held at Rockefeller Center in New York. The presentations highlighted the participants' contributions to the healthcare field.
The Medical Innovation Olympics is an initiative by Amedea Pharma designed to promote research and development in the health sector and provide a platform for emerging innovations. The competition draws attention from industry leaders and investors.